21st Annual Strategic Project & Portfolio Management for Pharma

Manage increased granularity and frequency of portfolio optimization and scenario planning and stay ahead of the curve with the right prioritization and execution strategy

17-18 June 2021

Virtual Conference

The economic turmoil has taken a toll on pharma and biotech companies who have been confronted by stringent regulations and budget cuts in R&D. Furthermore, Covid-19 and the related crisis has made the need for better prioritization and faster delivery of results under budget constraints more prominent than ever before.

As Pharmaceutical R&D becomes more cost-constrained and evolving portfolios require more investment, critical decision making and methodology have proved to be of crucial importance in PPM. The 21^st Edition marcus evans virtual conference on Project Portfolio Management (PPM) in Pharma taking place 17^th-18^th June, 2021 will look at overall portfolio strategy, with the clear understanding that decision making and portfolio prioritization is closely linked to robust evaluation and strong analytics; that the strategy needs continuously to be translated into right processes, tools and capabilities, and that clear decisions have to be taken to optimize investments while containing risks.

Attendees benefit from various case studies and a discussion platform that provides practical insights to solve their most urgent project portfolio management challenges.

Key Topics provide PPM professionals with an essential understanding of:

• How right processes/tools, realistic analysis and correct interpretation of data can be translated into market success, with efficient decision making.
• How to implement a successful PPM strategy by aligning with corporate business goals, maintaining portfolio prioritization and balance of value and risk, as well as enforcing capacity management.
• Keeping in touch with new opportunities and challenges brought by the impact of digital transformation on tools, drug development and product scope strategy.
• How to maximise portfolio value under limited budgets and benefit from early decision making.

Expert Speaker Panel includes:

• Thorsten Knoechel, Head of Project Management Methodology Biopharma|R&D Strategy and Business Operations, Merck
• Mandy Crowther, Head of Early Oncology Project Management, Astrazeneca
• Stephen Cho, Global Head, Portfolio Management & Learning, Novartis Institutes for Biomedical Research
• Daria Mikhailova, Senior Manager Portfolio Intelligence, STADA
• Ulrike Rauh, Senior Manager, Global Portfolio Management, Bayer AG
• Kevin Magalhaes, Associate Director, Program Management, Blueprint Medicines
• Magnus Ytterstad, VP of Customer Success and Analytics, Captario

For more information regarding this conference, please contact Ria Kiayia, riak@marcusevanscy.com or visit the website: https://bit.ly/3h7VzCj